Ascendis Pharma A/S Sustainability Reports

Ascendis Pharma A/S is a biopharmaceutical company that develops prodrug therapies using its proprietary TransCon technology. Its pipeline focuses on addressing clinical unmet needs within endocrinology rare diseases and oncology.

Sector: Manufacturing

Country: Denmark

Exchange: Nasdaq

ISIN: US04351P1012

16 reports from 2016 to 2025

• Ascendis Pharma A/S 2025 Annual Report
• Ascendis Pharma A/S 2025 Corporate Responsibility and P ESG Report
• Ascendis Pharma A/S 2024 Annual Report
• Ascendis Pharma A/S 2024 Sustainability and P ESG Report
• Ascendis Pharma A/S 2023 Annual Report